Breast augmentation falls in the areas of plastic and reconstructive surgery and gynecology (Heden, 2006). The operations are usually done for purely aesthetic reasons. The result is called colloquially silicone breasts, since most implants are made of silicone. The average age of the patients decreases continuously from year to year. Half of the women operated on in 2005 were less than 25 years, 2% under 18 years old (Aliyev, 2008). At the same time, the volume is bigger on the younger side. A breast augmentation is often a medically indicated surgery. This is partly the case, if there is a disfiguring malformation of the female breast, which is a disease in the sense of the Social Code. Dow Corning is a U.S. company specializing in the technology of silicones. It is the world leader in technology and innovations in the field of silicones. Dow Corning offers powerful solutions to meet the most diverse of more than 25,000 customers worldwide, with over 7000 products and services. The company is owned equally by The Dow Chemical Company and Corning, Incorporated, and generates more than half its annual sales outside the United States. There has been a lot of controversy in recent times relating implants of this company with breast cancer risks. Countless lawsuits and government bans have been seen in different parts of the world, especially Europe (Cunningham, 2009). In this context, the parties at risks are the countless women who have used implants or intend to do so in future. They are prone to the risks of implants. Also, considering that the risks are just rumors, their decision to opt for implants get influenced by the rumors. The other stakeholders include the people involved with Dow Corning, from investors to staffs (Yoshimura, 2007).